Article
Memantine inhibits calcium-permeable AMPA receptors.
Nature communications - 1 Jul 2025
Carrillo Elisa, Montaño Romero Alejandra, Gonzalez Cuauhtemoc U, Turcu Andreea L, Vázquez Santiago, Twomey Edward C, Jayaraman Vasanthi
Abstract excerpt
Memantine is an US Food and Drug Administration (FDA) approved drug that is thought to selectively inhibit NMDA-subtype of ionotropic glutamate receptors (NMDARs). NMDARs enable calcium influx into neurons and are critical for normal brain function. However, increasing evidence shows that calcium influx in neurological diseases is augmented by calcium-permeable AMPA-subtype ionotropic glutamate receptors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
